Prostate Cancer Treatment Guide:
Your Options Explained
CancerCareE is an independent information and introduction platform — not a healthcare provider. This page provides evidence-based information about prostate cancer treatment options, including proton therapy, robotic surgery, and advanced therapies. No marketing. Just clinical facts and transparent cost data.
💡 The Reality Check: Prostate cancer is one of the most treatable cancers when caught early. But not all prostate cancers need immediate treatment — active surveillance is a valid option for low-risk cases. The "best" treatment depends on your Gleason score, PSA level, age, and overall health.
Prostate Cancer Treatment Options
Treatment decisions depend on cancer stage, Gleason score, PSA level, and patient health status. Discuss all options with your urologist.
Active Surveillance
Monitoring low-risk prostate cancer with regular PSA tests, DREs, and periodic biopsies. No immediate treatment — only intervene if cancer progresses.
Robotic Surgery (Radical Prostatectomy)
Minimally invasive removal of the prostate gland using robotic assistance (da Vinci system). Precise, less blood loss, faster recovery.
Proton Therapy
Precise radiation therapy using protons instead of X-rays. Minimizes damage to surrounding tissue — reduces erectile dysfunction and urinary side effects.
PSMA-Targeted Therapy
Precision medicine using the Prostate-Specific Membrane Antigen biomarker. Includes PSMA PET scans and Lu-177 PSMA radioligand therapy for advanced disease.
Hormone Therapy (ADT)
Reducing testosterone levels to slow cancer growth. Used alone or in combination with radiation for intermediate and high-risk disease.
Chemotherapy & Immunotherapy
For metastatic castration-resistant prostate cancer. Options include docetaxel, cabazitaxel, and immunotherapy (sipuleucel-T).
Note: This is an overview of prostate cancer treatment options. Your treating urologist or oncologist will recommend the best option based on your specific case. Request a personalized review →
Prostate Cancer Treatment Cost by Country
Self-pay international patient pricing. Ranges reflect typical treatment episodes for surgery, radiation, and combination approaches.
| Country | Robotic Surgery | Proton Therapy | PSMA Therapy | Total Cost Range |
|---|---|---|---|---|
| 🇺🇸 United States | $40K-$70K | $50K-$80K | $60K-$100K | $50K-$120K |
| 🇩🇪 Germany | $30K-$50K | $40K-$60K | $50K-$70K | $40K-$80K |
| 🇰🇷 South Korea | $25K-$40K | $30K-$50K | $35K-$55K | $30K-$60K |
| 🇸🇬 Singapore | $30K-$45K | $35K-$55K | $40K-$60K | $35K-$65K |
| 🇹🇷 Turkey | $15K-$28K | $20K-$35K | $25K-$40K | $20K-$45K |
| 🇮🇳 India | $12K-$22K | $25K-$35K | $20K-$32K | $15K-$40K |
*Total Cost Range includes treatment, hospital stay, surgeon fees, anesthesia, and basic follow-up. It does not include international travel, accommodation, companion expenses, or treatment of complications.
Sources: Published hospital pricing, international patient department quotes, peer-reviewed cost analyses. Last updated: July 2026.
Disclaimer: Actual quotes vary by specific center, treatment protocol, and patient condition. Request a personalized estimate →
Who Qualifies for Prostate Cancer Treatment?
Eligibility for active treatment depends on risk stratification. Honest assessment saves unnecessary procedures and anxiety.
May Need Active Treatment If
- Gleason score 7+ (intermediate or high-risk)
- PSA >10 ng/mL
- Clinical stage T2b or higher
- Rapidly rising PSA (PSA doubling time <6 months)
- Younger age (<60) with higher-risk features
- Symptoms (urinary obstruction, pain, hematuria)
Active Surveillance May Be Appropriate If
- Gleason score 6 (low-risk)
- PSA <10 ng/mL
- Clinical stage T1c
- Older age (>70) with life expectancy <10 years
- No symptoms
- Willing to undergo regular monitoring (PSA, DRE, periodic biopsy)
Requires Expert Review If
- Gleason 7 (3+4 vs 4+3 — different risk profiles)
- PSA between 10-20 ng/mL
- Family history of prostate cancer
- African American ethnicity (higher risk)
- BRCA1/BRCA2 mutations
- Previous negative biopsy but persistently rising PSA
Countries with Prostate Cancer Treatment Programs
Vetted institutions offering prostate cancer treatment across multiple destinations.
Frequently Asked Questions
Common questions about prostate cancer treatment options.
Treatment options for prostate cancer include active surveillance, surgery (radical prostatectomy), radiation therapy (including proton therapy), hormone therapy, chemotherapy, immunotherapy, and targeted therapies like PSMA-targeted therapy. The choice depends on cancer stage, Gleason score, PSA level, and patient health status.
Proton therapy is a type of radiation therapy that uses protons instead of X-rays. It delivers radiation more precisely to the tumor, reducing damage to surrounding healthy tissue. This is particularly important for prostate cancer because it minimizes side effects like erectile dysfunction and urinary incontinence. Proton therapy is available in Germany, South Korea, USA, and increasingly in Turkey.
PSMA-targeted therapy is a precision medicine approach that uses the Prostate-Specific Membrane Antigen (PSMA) biomarker to deliver treatment directly to prostate cancer cells. PSMA PET scans detect cancer spread, and PSMA-targeted radioligand therapy (like Lu-177 PSMA) delivers radiation directly to cancer cells. These are available in Germany, South Korea, and the USA.
Costs vary significantly by country: USA ($50,000-$120,000), Germany ($40,000-$80,000), South Korea ($30,000-$60,000), Turkey ($20,000-$45,000), Singapore ($35,000-$65,000). Robotic surgery and proton therapy are at the higher end of these ranges. Total cost includes treatment, hospital stay, and follow-up care.
Yes. Top prostate cancer treatment centers in Germany, South Korea, Singapore, Turkey, India, and the USA treat international patients. Many have dedicated international patient departments, English-speaking staff, and transparent pricing. CancerCareE can introduce you to vetted institutions at your request.
Not Sure Which Treatment Option Is Right for You?
Submit your case for a free, no-obligation review by our network specialists. We'll help you understand your options and provide transparent cost estimates.
CancerCareE charges $0 to patients. We may receive a fixed referral fee from partner institutions after introduction. See our financial model →